Psykia Institute and Johns Hopkins School of Medicine to Study Breathwork as Treatment for PTSD
phase 1 funding goal reached
Psykia Institute, with the help and partnership of Jamie Wheal (author of "Stealing Fire") and his Flow Genome Project community plus Matt Kahl of Veterans for Natural Rights, has reached the Phase 1 funding goal for our Johns Hopkins School of Medicine study "Testing the Safety and Efficacy of Breathwork as Treatment for Veterans Suffering from Severe PTSD."
A positive result will open a new avenue of accessible treatment not only for PTSD, but also, potentially, for depression and other increasingly common afflictions not being adequately treated via traditional therapies.
Learn more here.
Psychedelic Medicine: From Tradition to Science @Founders Forum
June 12-13, 2019 | London, England
Psykia Institute is taking our ground breaking panel from Harvard University to the prestigious Founders Forum, where our CEO Delara Chizari will curate and moderate a panel discussion on psychedelic medicine, introducing experts in the field to an audience of health tech leaders from around the world.
Psychedelic Medicine: From Tradition to Science @ The National Autonomous University of Mexico
Fall, 2019 | Mexico city, mexico
Psykia Institute has been invited to curate a panel discussion on psychedelic medicine at the National Autonomous University of Mexico. This panel discussion will be in Spanish and include shamans representing multiple local indigenous cultures as well as Western psychiatry experts. To thank the shamans for their engagement, The Psykia Institute will donate funding to support projects by and for their local indigenous communities.
Wednesday, October 10 at 3:00pm | Broad Institute (Main Auditorium), Cambridge, MA
On October 10, 2018, The Psykia Institute, in partnership with The Harvard Medical School Program in Neuroscience and Program in Education, The Harvard Brain Science Initiative, The Broad Institute, and The Multidisciplinary Association for Psychedelic Studies (MAPS) presents “Psychedelic Medicine: From Tradition to Science.”
The panel discussion and audience Q&A marks a historic return to Harvard of the discussion of psychedelic medicine, its theory & practice, history & future: featuring best-selling author Michael Pollan, MAPS Founder & Executive Director Rick Doblin, psychedelic and brain science researchers Robin Carhart-Harris (Imperial College, London) and Matthew Johnson (Johns Hopkins School of Medicine), psychedelic therapist Anja Lozaiga-Velder (Centro Nierika), and psychiatrist Franklin King (Massachusets General Hospital), as moderated by psychiatrist and author Julie Holland.
Request a seat at the live event.